CannabIP: DEA Legalizes Some CBD Products

Cannabis IP patent

On August 26, 2019, the U.S. Drug Enforcement Administration (DEA) announced an expansion of a federal program allowing legalized cannabis research, by allowing additional applications from cannabis cultivators.  In doing so, the DEA will increase the pool of potential legal sourcing of cannabis for medical and scientific research.  Currently, the only cannabis that can be …

Continue Reading

CannabIP: U.S. Patent No. PP30,434 P3

Cannabis IP patent plantIP

U.S. Patent No. PP30,434 P3 (‘434) issued on April 23, 2019, for “Cannabis Plant Named ‘LW-BB1’.”  It was issued to inventors Andrew Alfred, Ian Dumpert, and Christopher Chapdeline of Denver, Colorado, and Kasey Greenwald of Evergreen, Colorado.  The applicant/assignee is Green Brands, LLC.  This patent is a plant patent under 35 U.S.C. §161, which protects …

Continue Reading

CannabIP: U.S. Patent No. 10,265,362 B2

Cannabis IP patent

U.S. Patent No. 10,265,362 B2 (‘362) issued on April 23, 2019, for “Ingestible Films Having Substances From Hemp or Cannabis.”  It was issued to applicant/inventor Scott Schaneville, of St. Petersburg, Florida. Figure 1-2 illustrates the claimed invention: The ‘362 patent discloses a new system for cannabis medical drug delivery, specifically through mucosal oral administration of …

Continue Reading

CannabIP: Second Circuit Refuses to Dismiss CBD Reclassification Case

Cannabis IP patent trademark

On May 30, 2019, the Court of Appeals for the Second Circuit in Washington v. Barr,[1] refused to dismiss outright a case where the plaintiffs alleged marijuana’s classification on the Drug Enforcement Agency (DEA)’s Schedule I list of the Controlled Substance Act (CSA) of the poses a “serious, life-of-death threat to their health.”  The Second …

Continue Reading

CannabIP: Hemp Now Accepted For PVP Protection

Cannabis IP plantIP PVP technology

On April 24, 2019, the U.S. Department of Agriculture (USDA) announced that the Plant Variety Protection Office (PVPO) will begin accepting applications for new, distinctive hemp-based seed-propagated plants for Plant Variety Protection (PVP) Certificates, as a result of the 2018 Farm Bill signed December 20, 2018.  Hemp is the non-psychoactive element of C. sativa plant, …

Continue Reading

CannabIP: U.S. Patent No. 10,179,694 B2

Cannabis IP patent

U.S. Patent No. 10,179,694 B2 (‘694) issued on November 20, 2018, for “Constant Illuminated Tamper-Resistant Plant Shipping Container.”  It was issued to applicant/inventor Larry D. Fenner, Jr. of Bellingham, Washington.  The assignee is THC Acquisition Corp. of Kelowna, British Columbia.  THC BioMed Ltd. is the parent company, a Canadian medical cannabis company. Figure 1 illustrates …

Continue Reading

CannabIP: U.S. Patent No. 10,206,963 B2

Cannabis IP patent

U.S. Patent No. 10,206,963 B2 (‘963) issued on January 15, 2019, for “Topical Medicinal Gel.”  It was issued to applicants/inventors Joan McMahon of Midland, Michigan and Stephanie House of Merrill, Michigan.  The ‘963 patent discloses a process for a topical composition containing cannabis.  The novel aspect is rather than containing a greasy emollient like olive …

Continue Reading

CannabIP: District Court Finds §101 Patent-Eligibility in First Cannabis Patent Litigation

101 Cannabis IP patent patent eligible subject matter

On April 17, 2019, Judge William J. Martinez denied an early motion for partial summary judgment for invalidity based patent-ineligible subject matter under 35 U.S.C. §101, in the first federal patent infringement case testing the patent claims of cannabinoid formulations.  Judge Martinez, sitting in the District of Colorado, found the patent-at-issue, U.S. Patent No. 9,730,911 …

Continue Reading